In an in-depth interview, Professor Martin Zizi, a molecular epidemiologist based in Mountain View, California, addresses the concerning issue of the rise in "turbo-cancers" and their possible link to mRNA vaccines against Covid-19. This medical analysis raises crucial questions about a phenomenon observed by many practitioners since 2021.
What is a turbo-cancer?
The term "turbo-cancer" does not appear in any official medical classification, such as the DSM (Diagnostic and Statistical Manual of Mental Disorders). It is a new concept that emerged to describe a novel clinical reality. Traditionally, cancer is a disease whose frequency increases with age and which develops gradually over several months, or even several years, before being diagnosed.
Turbo-cancers are characterized by a rapid progression: only 6 to 12 months can elapse between the onset of the first symptoms and death, without any identifiable risk factors being detected. This speed is explained by the absence of the usual silent phase, during which the immune system normally fights nascent cancer cells.
The immune system: our first line of defense against cancer
To understand this phenomenon, it's important to remember that our immune system acts as a natural barrier against cancer. According to commonly accepted medical teachings since the 1980s, we develop cancer-causing deficiencies several times a month, which our body efficiently eliminates.
The innate immune system recognizes cancer cells as abnormal and destroys them when their numbers are small. This natural protection explains why cancer typically takes between one and three years to be clinically detected. During this invisible period, the body successfully fights against tumor growth.
Disturbing clinical observations
Since 2021, healthcare professionals have been observing worrying anomalies. Professor Zizi reports the accounts of more than 250 general practitioners and specialists with whom he works. These practitioners are observing, in particular, cancers occurring in inappropriate age groups or affecting the wrong sex for the type of cancer in question.
For example, lung cancer in non-smoking women, an extremely rare condition, is on the rise. Some doctors even report diagnosing two cases in six months, whereas they hadn't encountered any in their twenty-year careers. These alarming signs are being repeated in Belgium, France, Australia, and the United States.
Shingles as a marker of immunodeficiency
An irrefutable clinical indicator emerged as early as 2021: the appearance of shingles-like skin lesions in 2 to 3% of people vaccinated with mRNA. This manifestation, which normally occurs in cases of extreme fatigue or serious illness, indicates a temporary decrease in immunity.
These post-vaccination shingles cases have particular characteristics: they last between two and four months, whereas classic shingles disappear in a few weeks. This prolonged duration indicates a more pronounced immunodeficiency. The varicella-zoster virus, normally kept under control by the immune system, reactivates when the latter weakens.
A mechanism comparable to AIDS
Without claiming that mRNA vaccines cause AIDS, Professor Zizi draws an instructive parallel. During the 1980s, HIV patients developed a progressive immunodeficiency that made them vulnerable to opportunistic infections and cancers, including Kaposi's sarcoma and certain lymphomas.
The current clinical picture presents similarities: recurrent infections, unusual parasitic diseases such as ocular toxoplasmosis, and especially rapidly progressing cancers. The crucial difference lies in the temporary nature of this post-vaccination immunodeficiency, unlike AIDS, which was permanent before the advent of triple therapy.
Emerging scientific data
A Japanese study published in the journal Cureus examines the statistical probability of developing cancer in people vaccinated against Covid-19. It reveals a significant increase between 2020 and 2023. Other scientific publications are beginning to document this increase, despite the difficulties encountered in getting this work accepted by peer review committees.
Paradoxically, some mainstream media outlets acknowledge the increase in cancers but immediately dismiss any link to vaccination, sometimes citing explanations such as climate change. This dissonance between clinical observation and public communication contributes to maintaining silence on this phenomenon.
Why the medical silence?
Several factors explain doctors' reluctance to speak publicly. First, there is social pressure: standing out within a professional group carries relational and financial risks. Second, there is institutional pressure: some doctors have been struck off the medical register for treating patients differently or criticizing official protocols.
Financial considerations also play a major role. The healthcare sector represents 16 to 20% of GDP in Western countries. A physician or hospital wishing to conduct research on turbo-cancers must secure funding, go through ethics committees, and navigate the scientific validation process. This undertaking exposes them to risks for their career and income.
The initial political decisions
Professor Zizi points to a pivotal moment between February 14 and March 9, 2020, a period during which Boris Johnson shifted from a policy of "mitigation" (targeted care for at-risk populations) to a policy of "suppression" (widespread lockdowns aimed at eradicating the virus). This decision was reportedly heavily influenced by Imperial College London.
This institution reportedly received $375 million from the Gates Foundation in the ten years preceding the crisis to fund research projects on new vaccines and mRNA platforms. This conflict of interest allegedly allowed private interests to influence political decisions, creating a systemic spiral that was difficult to stop.
Possible solutions to save lives
Faced with this situation, Professor Zizi proposes a two-pronged approach. First, he advocates a preventive monitoring program for individuals exhibiting warning signs, such as prolonged shingles, recurrent infections, or chronic fatigue. This screening would include specific tumor markers, a complete lymphocyte count, antimitochondrial antibodies, and coagulation tests.
These tests, costing between 1,000 and 2,000 euros and performed twice a year, would allow for the detection of cancers during their silent phase, before the onset of symptoms. This early detection would significantly increase the chances of survival.
Secondly, rapid intervention is crucial. Specialized units should be created within university hospitals, capable of quickly bringing together different medical specialties and initiating treatment within 8 to 15 days of a positive diagnosis. Traditional protocols, which require a delay of six weeks between diagnosis and treatment, are unsuitable for turbo-cancers.
A revealing example
The case of Professor Goldman, a Belgian immunologist specializing in cancer, illustrates the seriousness of the situation. After being vaccinated, he developed leukemia. Thanks to his professional network and the best available care, he went into remission. But seven days after his second dose, disaster struck: the tumor spread throughout his body. This rapid progression within a week demonstrates the particular virulence of these "turbo-cancers."
The imperative of transparency
According to Professor Zizi, we have hundreds of documented cases in Belgium alone, with similar observations in all Western countries that have made extensive use of messenger RNA technology. These warning signs, known since 2021-2022, require official recognition as well as the immediate implementation of appropriate monitoring and treatment protocols.
The lack of response from health authorities to these converging clinical observations is concerning. If early detection and rapid treatment protocols were implemented, approximately 90% of patients could be saved and achieve survival rates comparable to those of traditional cancers.
The issue of turbo-cancers extends beyond the medical realm to encompass matters of democratic transparency, research independence, and the primacy of public health over economic interests. Only a rigorous, dispassionate, and transparent scientific approach will allow for an accurate assessment of the phenomenon's extent and the effective protection of the population.
0 Comment:
Post a Comment